Highly Potent Compounds

Less than 1 min 22/11/20
Author name: John Ross

Getting a Handle on High Potency

Pharmaceutical products based on highly potent APIs (HPAPIs) are typically only needed in small doses, but their inherent potency presents pharma manufacturers with an important issue: safe manufacture. For pharma companies to manufacture in-house, significant investment would be required to meet today’s regulatory expectations for safe handling of HPAPIs.

Our President, John Ross, sat down with The Medicine Maker and other industry leaders to explore the trends shaping the HPAPI market and discuss the challenges of working with these compounds. Read the full article here.


Related Content